2-(Chloromethyl)-6,7-dimethoxyquinazolin-4(3H)-one, 95.0%, 1g

7-Phenyl-6,8-dioxaspiro[3.5]nonane-2-carboxylic acid, 97%, 100mg

[S(R)]-N-[(1S)-2-(Diphenylphosphino)-1-[2-(diphenylphosphino)phenyl]ethyl]]-2-methyl-N,2-dimethyl-2-propanesulfinamide, 95%, 250mg

4-Chloro-7-(diethylamino)-2-oxo-2H-chromene-3-carbaldehyde, 95%, 250mg

1,4-Dinitro-1H-pyrazole, 100mg

3',4',5',6'-Tetrahydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one, 85.0%, 5g

Supports d'échantillon pour tube 13–16 mm, 1 pièce

(Trans,trans)-4-methoxy-4'-propyl-1,1'-bi(cyclohexane), 97.0%, 25g

1-(7-BROMOQUINOLIN-4-YL)ETHANONE, 97.0%, 100mg

2-Morpholino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinonitrile, 95.0%, 1g

5-Amino-1,2,4-thiadiazole, 97.0%, 5g

Vinyl n-Octanoate (stabilized with MEHQ)>99.0%(GC)25mL

TERT-BUTYL 4-FLUORO-5-OXOAZEPANE-1-CARBOXYLATE, 95.0%, 100mg